The best Bull and Bear pitches based on recency and number of recommendations.
Celator has rebounded modestly from the all-time low of 1.3 achieved a few weeks ago but has still been a huge disappointment to its rabid retail followers over the last year. The decline in share price barely paused after the company reported a… More
I wish I could say I've carefully studied the data and trial design in order to predict failure in the phase III study of Vyxeos for AML later this month, but that would be a huge lie and lately I've been trying to tell many small lies rather than… More
Read the most recent pitches from players about CPXX.DL.
Find the members with the highest scoring picks in CPXX.DL.
See what the Wall Street professionals think, according to their public statements and filings.